| 中文同義詞: | 泊沙康唑非對映異構體2;泊沙康唑非對映異構體2(R,S,R,R);(3S,5R,2R,3R)-泊沙康唑;泊沙康唑雜質05;4-[4-[4-[4-[[(3S,5R)-5-(2,4-二氟苯基)四氫-5-(1H-1,2,4-三唑-1-基甲基)-3-呋喃基]甲氧基]苯基]-1-哌嗪基]苯基]-2-[(1R,2R)-1-乙基-2-羥丙基]-2,4-二氫-3H-1,2,4- 三唑-3-酮;11(3S,5R,2R,3R)-泊沙康唑;泊沙康唑雜質D2;1,4-脫水-2,3,5-三脫氧-4-C-(2,4-二氟苯基)-2-[[4-[4-[1-[(1R,2R)-1-乙基-2-羥丙基]-1,5-二氫-5-氧代-4H-1,2,4-三唑-4-基]苯基]-1-哌嗪基]苯氧基]甲基]-5-(1H-1,2,4-三唑-1-基)-D-赤-戊糖醇 |
| 英文同義詞: | Posaconazole DiastereoisoMer 2;(3S,5R,2R,3R)-posaconazole;Posacozole Diastereoisomer 2 (R,S,R,R);D-erythro-Pentitol, 1,4-anhydro-2,3,5-trideoxy-4-C-(2,4-difluorophenyl)-2-[[4-[4-[4-[1-[(1R,2R)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-5-(1H-1,2,4-triazol-1-yl)-;Posaconazole Impurity(S,R,R,R);Posaconazole DiastereoisoMer 2 ISO 9001：2015 REACH;4-(4-(4-(4-(((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2-((2R,3R)-2-hydroxypentan-3-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one;1,4-Anhydro-2,3,5-trideoxy-4-C-(2,4-difluorophenyl)-2-[[4-[4-[4-[1-[(1R,2R)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-5-(1H-1,2,4-triazol-1-yl)-D-erythro-pentitol |